In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus
Hepatitis delta virus (HDV) can dramatically worsen liver disease in patients coinfected with hepatitis B virus (HBV). No effective medical therapy exists for HDV. The HDV envelope requires HBV surface antigen proteins provided by HBV. Once inside a cell, however, HDV can replicate its genome in the...
Kaydedildi:
| Yayımlandı: | J Clin Invest |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Clinical Investigation
2003
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166292/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12897208/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI17704 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
